Streetbeat News

Stock Prices

CRWD

JMP Securities analyst Trevor Walsh has reaffirmed a Market Outperform rating on CrowdStrike Holdings (NASDAQ:CRWD) and increased the price target from $235 to $330.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:03 pm

ABBV

GS

TSM

On CNBC's Halftime Report, experts shared their final trades, highlighting Taiwan Semiconductor Manufacturing (TSM), AbbVie (ABBV), and Goldman Sachs Group (GS) as stocks to watch.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 6:02 pm

LFVN

Lifevantage (NASDAQ:LFVN) is expected to release its quarterly earnings report on Tuesday, 2024-01-30, with analysts estimating an EPS of $0.04. Investors are looking for an earnings beat and positive guidance for future growth. Lifevantage's past earnings performance has shown significant stock price changes post-earnings announcement. Shares are currently trading at $5.78, up 47.75% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 6:00 pm

AX

Axos Financial (NYSE:AX) is scheduled to release its quarterly earnings report on January 30, 2024. Analysts predict an EPS of $1.38. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, Axos Financial's stock price has shown volatility post-earnings, with a 7.88% drop after beating EPS last quarter. Over the past 52 weeks, AX shares have increased by 17.06%, trading at $55.71 as of January 26.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 6:00 pm

POWL

Powell Industries (NASDAQ:POWL) is expected to release its quarterly earnings report on January 30, 2024, with an estimated EPS of $0.84. Investors are looking for an earnings beat and positive guidance for future growth. Despite beating EPS estimates in the past four quarters, the stock's reaction varied, with a 6.0% drop after the last report. Over the last year, POWL shares have risen 96.85%, trading at $76.83 as of January 26.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 6:00 pm

GILD

HOOK

MRK

RHHBY

Roche Holdings AG (OTC:RHHBY) has terminated its collaboration with HOOKIPA Pharma Inc (NASDAQ:HOOK) on the HB-700 program for KRAS mutated cancers. HOOKIPA will regain full control of the program in April 2024 and plans to submit an IND in Q1 2024, seeking a new partner. HOOKIPA is refocusing on its HB-200 program for HPV16+ HNSCC and infectious disease programs with Gilead Sciences Inc (NASDAQ:GILD). The company will reduce its workforce by 30% and rebalance costs. HOOKIPA's cash position was $117.5 million as of December 31, 2023, bolstered by Gilead's purchase of 15 million shares in December. HOOKIPA's stock price dropped 15% to $0.59.

Portfolio Pulse from Vandana Singh

January 29, 2024 | 5:55 pm

DKNG

MGM

PENN

Bank of America analyst Shaun C. Kelley maintains a Buy rating on DraftKings Inc (NASDAQ:DKNG) with a price target of $45, citing strong financials despite increased competition in the sports betting sector. Kelley raised revenue estimates for DraftKings for fiscal years 2024 and 2025 and anticipates a Q4 earnings beat and a possible guidance raise for 2024. DraftKings is expected to report Q4 earnings on Feb. 15, with analysts predicting an EPS of 9 cents and revenue of $1.241 billion. DraftKings shares have risen 1.64% to $39.10, with a 160% increase over the past year.

Portfolio Pulse from Chris Katje

January 29, 2024 | 5:53 pm

WAL

RBC Capital analyst Jon Arfstrom has maintained an Outperform rating on Western Alliance (NYSE:WAL) and increased the price target from $74 to $78.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 5:48 pm

ALK

BA

UAL

BofA Securities analyst Ronald J. Epstein discussed the FAA's production freeze of Boeing's 737 MAX and its implications for MAX 7 and MAX 10 certification with Chris Brady, author of The Boeing 737 Technical Guide. The freeze may lead to customer loss as airlines like United Airlines may seek other providers due to delivery delays. Boeing aims to fix the anti-ice system by June 2026. Epstein maintains a Neutral rating on Boeing with a $225 price target. Boeing shares are slightly down.

Portfolio Pulse from Lekha Gupta

January 29, 2024 | 5:44 pm

BABA

JD

PDD

US-listed Chinese stocks are experiencing increased volatility and trading lower following a Hong Kong court's order to liquidate China Evergrande, a major real estate company in China.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 5:44 pm